Literature DB >> 19301571

Management of gestational trophoblastic neoplasia with 5-fluorouracil and actinomycin D in northern China.

Ying Zhao1, Weiyuan Zhang, Wei Duan.   

Abstract

OBJECTIVE: To study risk factors associated with the number of chemotherapy courses required to obtain normal beta-human chorionic gonadotropin (beta-hCG) levels and evaluate the effectiveness of combination chemotherapy using 5-fluorouracil (5-FU) and actinomycin D (Act D) (FA) for gestational trophoblastic neoplasia (GTN). STUDY
DESIGN: A retrospective study of GTN cases from January 1995 to July 2007 at the Beijing Obstetrics and Gynecology Hospital was performed.
RESULTS: During the study period, 240 cases of GTN were diagnosed and managed at our institution. A stepwise regression analysis revealed that the interval between evacuation and chemotherapy, parity, age and beta-hCG level were associated with number of chemotherapy courses required to obtain normal beta-hCG levels. In addition to 4 patients with placental site trophoblastic tumor, FA was used in 218 patients (136 low risk and 82 high risk).
CONCLUSION: Early detection of GTN and timely administration of chemotherapy decreases the number of chemotherapy courses required. The combination chemotherapy of 5-FU and Act D is effective in low- and high-risk patients with GTN, but not in patients with placental site trophoblastic tumor; it can be used as primary chemotherapy regimen in high-risk patients with GTN, except those with extensive metastases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19301571

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  5 in total

1.  Partial hydatidiform mole progression into invasive mole with lung metastasis following in vitro fertilization.

Authors:  Xi Zhou; Yongli Chen; Yongmei Li; Zhao Duan
Journal:  Oncol Lett       Date:  2011-12-28       Impact factor: 2.967

2.  FIGO stage IV gestational choriocarcinoma misdiagnosed as pulmonary tuberculosis: A case report.

Authors:  Lingyun Yang; Pang Xu; Mingrong Xi; Hongjing Wang
Journal:  Oncol Lett       Date:  2015-07-01       Impact factor: 2.967

Review 3.  Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.

Authors:  Mo'iad Alazzam; John Tidy; Raymond Osborne; Robert Coleman; Barry W Hancock; Theresa A Lawrie
Journal:  Cochrane Database Syst Rev       Date:  2016-01-13

4.  Real-World Study of Cisplatin, Etoposide, and Bleomycin Chemotherapy Regimen in Gestational Trophoblastic Neoplasia.

Authors:  Ming Wang; Lianna Shen; Xiaohong Xu; Wei Duan; Jinwei Miao; Weimin Kong; Li Su; Yumei Wu
Journal:  Biomed Res Int       Date:  2021-06-24       Impact factor: 3.411

Review 5.  Management of Chemoresistant and Quiescent Gestational Trophoblastic Disease.

Authors:  Siew-Fei Ngu; Karen K L Chan
Journal:  Curr Obstet Gynecol Rep       Date:  2014-01-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.